{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:06:28Z","timestamp":1791111988996,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00262-007-0374-4","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T14:13:27Z","timestamp":1185891207000},"page":"347-358","source":"Crossref","is-referenced-by-count":23,"title":["Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells"],"prefix":"10.1007","volume":"57","author":[{"given":"Elizabeth P.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,1]]},"reference":[{"key":"374_CR1","first-page":"1393","volume":"26","author":"B Singh","year":"2005","unstructured":"Singh B, Berry JA, Shoher A, Ramakrishnan V, Lucci A (2005) COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 26:1393\u20131399","journal-title":"Int J Oncol"},{"key":"374_CR2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ijc.11646","volume":"108","author":"Q Chen","year":"2004","unstructured":"Chen Q, Shinohara N, Abe T, Watanabe T, Nonomura K, Koyanagi T (2004) Significance of COX-2 expression in human renal cell carcinoma cell lines. Int J Cancer 108:825\u2013832","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"374_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2036.2000.014s1064.x","volume":"14","author":"RN Dubois","year":"2000","unstructured":"Dubois RN (2000) Review article: cyclooxygenase\u2014a target for colon cancer prevention. Aliment Pharmacol Ther 14(Suppl 1):64\u201367","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"374_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000086630","volume":"69","author":"S Samoha","year":"2005","unstructured":"Samoha S, Arber N (2005) Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side. Oncology 69(Suppl 1):33\u201337","journal-title":"Oncology"},{"key":"374_CR5","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","volume":"115","author":"S Nakao","year":"2005","unstructured":"Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S, Sonoda KH, Saijo Y, Nukiwa T, Strieter RM, Ishibashi T, Kuwano M, Ono M (2005) Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1beta-induced neovascularization and tumor growth. J Clin Invest 115:2979\u20132991","journal-title":"J Clin Invest"},{"key":"374_CR6","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.3748\/wjg.v11.i24.3724","volume":"11","author":"YH Zhi","year":"2005","unstructured":"Zhi YH, Liu RS, Song MM, Tian Y, Long J, Tu W, Guo RX (2005) Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma. World J Gastroenterol 11:3724\u20133728","journal-title":"World J Gastroenterol"},{"key":"374_CR7","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1158\/0008-5472.CAN-04-1177","volume":"64","author":"H Ito","year":"2004","unstructured":"Ito H, Duxbury M, Benoit E, Clancy TE, Zinner MJ, Ashley SW, Whang EE (2004) Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Res 64:7439\u20137446","journal-title":"Cancer Res"},{"key":"374_CR8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3904\/kjim.2005.20.3.198","volume":"20","author":"JH Park","year":"2005","unstructured":"Park JH, Kang KH, Kim SH, Lee JH, Cho CM, Kweon YO, Kim SK, Choi YH, Bae HI, Kim MS (2005) Expression of Cyclooxygenase-2 and Bcl-2 in human gastric adenomas. Korean J Intern Med 20:198\u2013204","journal-title":"Korean J Intern Med"},{"key":"374_CR9","first-page":"543","volume":"28","author":"GS Charames","year":"2006","unstructured":"Charames GS, Bapat B (2006) Cyclooxygenase-2 knockdown by RNA interference in colon cancer. Int J Oncol 28:543\u2013549","journal-title":"Int J Oncol"},{"issue":"3","key":"374_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.lungcan.2005.10.015","volume":"51","author":"S Han","year":"2006","unstructured":"Han S, Roman J (2006) COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals. Lung Cancer 51(3):283\u2013296","journal-title":"Lung Cancer"},{"key":"374_CR11","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1158\/1078-0432.CCR-05-0326","volume":"11","author":"ST Palayoor","year":"2005","unstructured":"Palayoor ST, Arayankalayil MJ, Shoaibi A, Coleman CN (2005) Radiation sensitivity of human carcinoma cells transfected with small interfering RNA Targeted against cyclooxygenase-2. Clin Cancer Res 11:6980\u20136986","journal-title":"Clin Cancer Res"},{"key":"374_CR12","doi-asserted-by":"crossref","first-page":"27613","DOI":"10.1074\/jbc.M201119200","volume":"277","author":"S Arico","year":"2002","unstructured":"Arico S, Pattingre S, Bauvy C, Gane P, Barbat A, Codogno P, Ogier-Denis E (2002) Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. J Biol Chem 277:27613\u201327621","journal-title":"J Biol Chem"},{"key":"374_CR13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1042\/bj20020279","volume":"366","author":"AJ Johnson","year":"2002","unstructured":"Johnson AJ, Hsu AL, Lin HP, Song X, Chen CS (2002) The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. Biochem J 366:831\u2013837","journal-title":"Biochem J"},{"key":"374_CR14","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1096\/fj.04-3274fje","volume":"19","author":"TJ Maier","year":"2005","unstructured":"Maier TJ, Janssen A, Schmidt R, Geisslinger G, Grosch S (2005) Targeting the beta-catenin\/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Faseb J 19:1353\u20131355","journal-title":"Faseb J"},{"key":"374_CR15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/jm030912m","volume":"47","author":"A Weber","year":"2004","unstructured":"Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G (2004) Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J Med Chem 47:550\u2013557","journal-title":"J Med Chem"},{"key":"374_CR16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/jnci\/94.23.1745","volume":"94","author":"J Zhu","year":"2002","unstructured":"Zhu J, Song X, Lin HP, Young DC, Yan S, Marquez VE, Chen CS (2002) Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. J Natl Cancer Inst 94:1745\u20131757","journal-title":"J Natl Cancer Inst"},{"key":"374_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0145-2126(03)00260-1","volume":"28","author":"RP Phipps","year":"2004","unstructured":"Phipps RP, Ryan E, Bernstein SH (2004) Inhibition of cyclooxygenase-2: a new targeted therapy for B-cell lymphoma? Leuk Res 28:109\u2013111","journal-title":"Leuk Res"},{"key":"374_CR18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/10428190310001654032","volume":"45","author":"B Hazar","year":"2004","unstructured":"Hazar B, Ergin M, Seyrek E, Erdogan S, Tuncer I, Hakverdi S (2004) Cyclooxygenase-2 (Cox-2) expression in lymphomas. Leuk Lymphoma 45:1395\u20131399","journal-title":"Leuk Lymphoma"},{"key":"374_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0145-2126(03)00183-8","volume":"28","author":"T Wun","year":"2004","unstructured":"Wun T, McKnight H, Tuscano JM (2004) Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma. Leuk Res 28:179\u2013190","journal-title":"Leuk Res"},{"key":"374_CR20","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0002-9440(10)61244-8","volume":"167","author":"P Secchiero","year":"2005","unstructured":"Secchiero P, Barbarotto E, Gonelli A, Tiribelli M, Zerbinati C, Celeghini C, Agostinelli C, Pileri SA, Zauli G (2005) Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. Am J Pathol 167:1599\u20131607","journal-title":"Am J Pathol"},{"issue":"1","key":"374_CR21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clim.2005.12.012","volume":"120","author":"EP Ryan","year":"2006","unstructured":"Ryan EP, Pollock SJ, Kaur K, Felgar RE, Bernstein SH, Chiorrazi N, Phipps RP (2006) Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells. Clin Immunol 120(1):76\u201390","journal-title":"Clin Immunol"},{"key":"374_CR22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.cdd.4400959","volume":"9","author":"JS Armstrong","year":"2002","unstructured":"Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Knox SJ (2002) Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ 9:252\u2013263","journal-title":"Cell Death Differ"},{"key":"374_CR23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.2830470318","volume":"47","author":"AM Ferraris","year":"1994","unstructured":"Ferraris AM, Rolfo M, Mangerini R, Gaetani GF (1994) Increased glutathione in chronic lymphocytic leukemia lymphocytes. Am J Hematol 47:237\u2013238","journal-title":"Am J Hematol"},{"key":"374_CR24","first-page":"R294","volume":"274","author":"A Margalit","year":"1998","unstructured":"Margalit A, Hauser SD, Zweifel BS, Anderson MA, Isakson PC (1998) Regulation of prostaglandin biosynthesis in vivo by glutathione. Am J Physiol 274:R294\u2013R302","journal-title":"Am J Physiol"},{"key":"374_CR25","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0006-2952(03)00504-5","volume":"66","author":"A Pompella","year":"2003","unstructured":"Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF (2003) The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66:1499\u20131503","journal-title":"Biochem Pharmacol"},{"key":"374_CR26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0192-0561(94)90105-8","volume":"16","author":"ER Fedyk","year":"1994","unstructured":"Fedyk ER, Phipps RP (1994) Reactive oxygen species and not lipoxygenase products are required for mouse B-lymphocyte activation and differentiation. Int J Immunopharmacol 16:533\u2013546","journal-title":"Int J Immunopharmacol"},{"key":"374_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/clim.2001.5181","volume":"103","author":"J Padilla","year":"2002","unstructured":"Padilla J, Leung E, Phipps RP (2002) Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin Immunol 103:22\u201333","journal-title":"Clin Immunol"},{"key":"374_CR28","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.4049\/jimmunol.174.5.2619","volume":"174","author":"EP Ryan","year":"2005","unstructured":"Ryan EP, Pollack SJ, Murant TI, Bernstein SH, Felgar RE, Phipps RP (2005) Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J Immunol 174:2619\u20132626","journal-title":"J Immunol"},{"key":"374_CR29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/smim.1994.1037","volume":"6","author":"MR Kehry","year":"1994","unstructured":"Kehry MR, Castle BE (1994) Regulation of CD40 ligand expression and use of recombinant CD40 ligand for studying B cell growth and differentiation. Semin Immunol 6:287\u2013294","journal-title":"Semin Immunol"},{"key":"374_CR30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/039463200301600107","volume":"16","author":"ML Capone","year":"2003","unstructured":"Capone ML, Tacconelli S, Sciulli MG, Patrignani P (2003) Clinical pharmacology of selective COX-2 inhibitors. Int J Immunopathol Pharmacol 16:49\u201358","journal-title":"Int J Immunopathol Pharmacol"},{"key":"374_CR31","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2004-05-1957","volume":"105","author":"AJ Johnson","year":"2005","unstructured":"Johnson AJ, Smith LL, Zhu J, Heerema NA, Jefferson S, Mone A, Grever M, Chen CS, Byrd JC (2005) A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism. Blood 105:2504\u20132509","journal-title":"Blood"},{"key":"374_CR32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/bjc.1995.470","volume":"72","author":"JJ Eady","year":"1995","unstructured":"Eady JJ, Orta T, Dennis MF, Stratford MR, Peacock JH (1995) Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response. Br J Cancer 72:1089\u20131095","journal-title":"Br J Cancer"},{"key":"374_CR33","doi-asserted-by":"crossref","first-page":"9943","DOI":"10.1073\/pnas.87.24.9943","volume":"87","author":"FJ Staal","year":"1990","unstructured":"Staal FJ, Roederer M, Herzenberg LA, Herzenberg LA (1990) Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 87:9943\u20139947","journal-title":"Proc Natl Acad Sci USA"},{"key":"374_CR34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1073\/pnas.0408381102","volume":"102","author":"F Cerimele","year":"2005","unstructured":"Cerimele F, Battle T, Lynch R, Frank DA, Murad E, Cohen C, Macaron N, Sixbey J, Smith K, Watnick RS, Eliopoulos A, Shehata B, Arbiser JL (2005) Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt\u2019s lymphoma. Proc Natl Acad Sci USA 102:175\u2013179","journal-title":"Proc Natl Acad Sci USA"},{"key":"374_CR35","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/blood-2002-08-2512","volume":"101","author":"Y Zhou","year":"2003","unstructured":"Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P (2003) Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 101:4098\u20134104","journal-title":"Blood"},{"key":"374_CR36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jim.2006.01.018","volume":"311","author":"TC George","year":"2006","unstructured":"George TC, Fanning SL, Fitzgeral-Bocarsly P, Medeiros RB, Highfill S, Shimizu Y, Hall BE, Frost K, Basiji D, Ortyn WE, Morrissey PJ, Lynch DH (2006) Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J Immunol Methods 311:117\u2013129","journal-title":"J Immunol Methods"},{"key":"374_CR37","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/cyto.a.20306","volume":"69","author":"WE Ortyn","year":"2006","unstructured":"Ortyn WE, Hall BE, George TC, Frost K, Basiji DA, Perry DJ, Zimmerman CA, Coder D, Morrissey PJ (2006) Sensitivity measurement and compensation in spectral imaging. Cytometry A 69:852\u2013862","journal-title":"Cytometry A"},{"key":"374_CR38","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.4049\/jimmunol.177.8.5068","volume":"177","author":"DM Ray","year":"2006","unstructured":"Ray DM, Akbiyik F, Phipps RP (2006) The peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) ligands 15-deoxy-{delta}12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPAR{gamma}-independent mechanisms. J Immunol 177:5068\u20135076","journal-title":"J Immunol"},{"key":"374_CR39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1349-7006.2002.tb01294.x","volume":"93","author":"H Inoue","year":"2002","unstructured":"Inoue H, Takemura H, Kawai Y, Yoshida A, Ueda T, Miyashita T (2002) Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism. Jpn J Cancer Res 93:582\u2013590","journal-title":"Jpn J Cancer Res"},{"key":"374_CR40","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1016\/S0021-9258(17)42703-7","volume":"259","author":"GF Seelig","year":"1984","unstructured":"Seelig GF, Simondsen RP, Meister A (1984) Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. J Biol Chem 259:9345\u20139347","journal-title":"J Biol Chem"},{"key":"374_CR41","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1006\/bbrc.1996.1888","volume":"229","author":"I Rahman","year":"1996","unstructured":"Rahman I, Bel A, Mulier B, Lawson MF, Harrison DJ, Macnee W, Smith CA (1996) Transcriptional regulation of gamma-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. Biochem Biophys Res Commun 229:832\u2013837","journal-title":"Biochem Biophys Res Commun"},{"key":"374_CR42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","volume":"10","author":"PT Schumacker","year":"2006","unstructured":"Schumacker PT (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10:175\u2013176","journal-title":"Cancer Cell"},{"key":"374_CR43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.20639","volume":"113","author":"H Ding","year":"2005","unstructured":"Ding H, Han C, Zhu J, Chen CS, D\u2019Ambrosio SM (2005) Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9. Int J Cancer 113:803\u2013810","journal-title":"Int J Cancer"},{"key":"374_CR44","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1096\/fj.02-0947fje","volume":"17","author":"V Jendrossek","year":"2003","unstructured":"Jendrossek V, Handrick R, Belka C (2003) Celecoxib activates a novel mitochondrial apoptosis signaling pathway. Faseb J 17:1547\u20131549","journal-title":"Faseb J"},{"key":"374_CR45","doi-asserted-by":"crossref","unstructured":"Johnson AJ, Smith LL, Zhu J, Heerema NA, Jefferson S, Mone A, Grever M, Chen CS, Byrd JC (2005) A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma via a caspase and Bcl-2 independent mechanism. Blood 15; 105(6):2504\u20132509","DOI":"10.1182\/blood-2004-05-1957"},{"key":"374_CR46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ijc.20438","volume":"112","author":"H Zhong","year":"2004","unstructured":"Zhong H, Willard M, Simons J (2004) NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms. Int J Cancer 112:585\u2013595","journal-title":"Int J Cancer"},{"key":"374_CR47","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.leu.2403043","volume":"17","author":"JS Carew","year":"2003","unstructured":"Carew JS, Zhou Y, Albitar M, Carew JD, Keating MJ, Huang P (2003) Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 17:1437\u20131447","journal-title":"Leukemia"},{"key":"374_CR48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.imlet.2004.04.004","volume":"94","author":"J Nilsson","year":"2004","unstructured":"Nilsson J, Soderberg O, Nilsson K, Rosen A (2004) Differentiation-associated redox-regulation in human B cell lines from stem cell\/pro-B to plasma cell. Immunol Lett 94:83\u201389","journal-title":"Immunol Lett"},{"key":"374_CR49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","volume":"93","author":"M Tsujii","year":"1998","unstructured":"Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705\u2013716","journal-title":"Cell"},{"key":"374_CR50","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2741\/1429","volume":"9","author":"AJ Chu","year":"2004","unstructured":"Chu AJ, Chou TH, Chen BD (2004) Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications. Front Biosci 9:2697\u20132713","journal-title":"Front Biosci"},{"key":"374_CR51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/jnci\/djh038","volume":"96","author":"ET Chang","year":"2004","unstructured":"Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D, Mueller NE (2004) Aspirin and the risk of Hodgkin\u2019s lymphoma in a population-based case-control study. J Natl Cancer Inst 96:305\u2013315","journal-title":"J Natl Cancer Inst"},{"key":"374_CR52","doi-asserted-by":"crossref","unstructured":"Beiderbeck AB, Holly EA, Sturkenboom MC, Coebergh JW, Stricker BH, Leufkens HG (2003) Prescription medications associated with a decreased risk of non-Hodgkin\u2019s Lymphoma. Am J Epidemiol 157:510\u2013516","DOI":"10.1093\/aje\/kwg004"},{"key":"374_CR53","doi-asserted-by":"crossref","unstructured":"Ellen T, Chang KEmS, Henrik Hjalgrim, Claudia Sch\u00f6llkopf, Anna, Porwit-MacDonald CSm, Edneia Tani, Francesco d\u2019Amore, Mads Melbye, Hans-Olov Adami aBG (2005) Medication use and risk of non-Hodgkin\u2019s Lymphoma. Am J Epidemiol 162:965\u2013974","DOI":"10.1093\/aje\/kwi311"},{"key":"374_CR54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1568009043481632","volume":"4","author":"CV Rao","year":"2004","unstructured":"Rao CV, Reddy BS (2004) NSAIDs and chemoprevention. Curr Cancer Drug Targets 4:29\u201342","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-007-0374-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-007-0374-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-007-0374-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T21:25:39Z","timestamp":1629494739000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-007-0374-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1007\/s00262-007-0374-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}